Table 2 IHC/MSI profile according to type of cancer
Tumour type | IHC performed | PMS2 expressed | Loss of PMS2 expression | MSI performed | MSS | MSI high | MSI low |
|---|---|---|---|---|---|---|---|
Colorectal | 11 | 9 | 2 | 9 | 9 | ||
Gastric | 2 | 2 | 0 | 2 | 1 | 1 | |
Endometrial | 4 | 3 | 1 | 3 | 2 | 1 | |
Prostate | 1 | 1 | 0 | 1 | 1 | ||
Ovarian | 1 | 1 | 0 | 1 | 1 | ||
Breast | 3 | 3 | 0 | 3 | 1 | 1 | 1 |
Sarcoma | 1 | 1 | 0 | 1 | 1 | ||
Renal | 1 | 1 | 0 | 1 | 1 | ||
Sum | 24 | 21 (87.5%) | 3 | 21 | 2 | 15 (71.4%) | 4 (19.0%) |